Providing value to biopharma and diagnostic companies
at different stages of development, suporting your efforts
from bench to bedside.
SimplicityBio’s machine learning platform - BOSS - analyses your biological, clinical, digital data streams to extract knowledge and insight that can lead to disease mechanism understanding, drug target discovery, biomarker identification, patient stratification, and drug repositioning. Our unique multi-biomarker agnostic approach discovers novel combinations of new (or validated) biomarkers from structured data provided by our clients. The resulting models are also human interpretable and robust. Clients have secure access to BOSS, in order to investigate the raw results, query models, and also analyse their own data.